Alogliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits

BACKGROUND: There is increasing evidence implicating atrial mitochondrial dysfunction in the pathogenesis of atrial fibrillation. In this study, we explored whether alogliptin, a dipeptidyl peptidase‐4 inhibitor, can prevent mitochondrial dysfunction and atrial remodeling in a diabetic rabbit model....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaowei, Zhang, Zhiwei, Zhao, Yungang, Jiang, Ning, Qiu, Jiuchun, Yang, Yajuan, Li, Jian, Liang, Xue, Wang, Xinghua, Tse, Gary, Li, Guangping, Liu, Tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524117/
https://www.ncbi.nlm.nih.gov/pubmed/28507060
http://dx.doi.org/10.1161/JAHA.117.005945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524117/
https://www.ncbi.nlm.nih.gov/pubmed/28507060
http://dx.doi.org/10.1161/JAHA.117.005945

Ejemplares similares